Unique stem cell lines identifier | Cell line 1: CHOPi008-A Cell line 2: CHOPi008-C |
Alternative name(s) of stem cell lines | Cell line 1: TMD145.T21.G1S Cell line 2: DS145.T21.G1 |
Institution | Children’s Hospital of Philadelphia |
Contact information of distributor | Stella T. Chou, MD chous@chop.edu |
Type of cell lines | iPSC |
Origin | Human |
Additional origin info | Age: 8 days Sex: Male Ethnicity if known: White |
Cell Source | Peripheral blood |
Clonality | Clonal |
Method of reprogramming | Sendai virus |
Genetic Modification | Yes |
Type of Genetic Modification | Spontaneous mutation/chromosomal abnormality (germline Trisomy 21 with and without somatic GATA1 mutation) |
Evidence of the reprogramming transgene loss (including genomic copy if applicable) | qRT-PCR |
Associated disease | Transient myeloproliferative disorder |
Gene/locus | CHOPi008-A: GATA1 c.3_4insG (GATA1s) CHOPi008-C: GATA1 |
Date archived/stock date | August 2022 |
Cell line repository/bank |
https://hpscreg.eu/cell-line/CHOPi008-A
https://hpscreg.eu/cell-line/CHOPi008-C |
Ethical approval | Children’s Hospital of Philadelphia, Committees for the Protection of Human Subjects (IRB), IRB 13-010038 |